Uncommon advocacy for the common good.
We champion the causes of real people—workers, consumers, small business owners, investors, and whistleblowers—working to deliver corporate reforms and fair markets for the common good.
Welcome to our website
Whether you’re looking for representation, a new career opportunity, or experienced co-counsel, we’re pleased to have you here.
News & Insights
Today’s news, tomorrow’s change.
Takeda Antitrust Verdict Seen as Big Win in Generic-Drug Fight
Bloomberg Law
Sharon Robertson weighs in on the importance of the $885 million antitrust jury verdict against Takeda Pharmaceuticals Co. Ltd. and helping private plaintiffs challenge deals delaying cheaper generic drugs.
SEC Semiannual Reporting Option Stirs Friction
Accounting Today
Justices Won’t Review Denial of Luxottica Arbitration Push
Law360
The PSLRA at 30 — Lessons, Impact, and the Road Ahead
Shareholder Advocate Spring 2026